Figure 2.
Meta-analysis of tumor response.
Compound Kushen Injection (C.K.I.) plus transcatheter arterial chemoembolization (TACE) versus TACE alone for tumor response (CR+PR) of patients with unresectable hepatocellular carcinoma.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.